Clinical Trial Update: COVID-19 and Cancer Patients

View source ↗

Summary

This Imperial College London-sponsored clinical trial evaluating cancer patients with SARS-CoV-2 infection has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Snippet

Sponsor: Imperial College London | Conditions: Cancer, Sars-CoV2 | Status: COMPLETED